Therefore, Cannone et al. (2021) genotyped the Stop Heart Failure cohort for rs198389, assessed cardiovascular phenotype along with circulating BNP levels and performed a follow up analysis to assess risk of LVD using echocardiography as well as risk for adverse multiple cardiovascular outcomes. The gene discussed is NPPB; the disease is heart failure.